​

Accolade (ACCD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ACCD Stock Forecast

Accolade (ACCD) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $7.03, with a high of $7.03 and a low of $7.03. This represents a 0.14% increase from the last price of $7.02.

$3 $5 $7 $9 $11 $13 High: $7.03 Avg: $7.03 Low: $7.03 Last Closed Price: $7.02

ACCD Stock Rating

Accolade stock's rating consensus is Hold, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (43.75%), 9 Hold (56.25%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 16 0 9 7 Strong Sell Sell Hold Buy Strong Buy

ACCD Price Target Upside V Benchmarks

TypeNameUpside
StockAccolade0.14%
SectorHealthcare Stocks 35.25%
IndustryHealthcare Information Services Stocks 36.10%

Price Target Trends

1M3M12M
# Anlaysts-110
Avg Price Target-$7.03$7.96
Last Closing Price$7.02$7.02$7.02
Upside/Downside-0.14%13.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--11--11
Mar, 251110--12
Feb, 251110--12
Jan, 253810--21
Dec, 24383--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 04, 2025Piper Sandler$7.03$6.951.15%0.14%
Jan 09, 2025David GrossmanStifel Nicolaus$7.03$6.862.48%0.14%
Jan 08, 2025Richard CloseCanaccord Genuity$7.03$6.862.48%0.14%
Jun 28, 2024David GrossmanStifel Nicolaus$8.00$3.58123.46%13.96%
Jun 28, 2024Richard CloseCanaccord Genuity$13.00$6.39103.44%85.19%
Jun 28, 2024Ryan MacDonaldNeedham$8.00$6.3925.20%13.96%
Jun 28, 2024Jailendra SinghTruist Financial$9.00$6.3940.85%28.21%
Jun 28, 2024Stephanie DavisBarclays$5.50$6.39-13.93%-21.65%
Jun 28, 2024Gil LuriaD.A. Davidson$5.00$6.39-21.75%-28.77%
Apr 30, 2024Stan BerenshteynWells Fargo$10.00$8.1922.10%42.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 04, 2025Piper SandlerOverweightNeutraldowngrade
Jan 09, 2025Raymond JamesOutperformMarket Performdowngrade
Jan 08, 2025NeedhamBuyHolddowngrade
Jan 08, 2025William BlairMarket Performdowngrade
Oct 09, 2024StephensBuyBuyhold
Oct 04, 2024Raymond JamesOutperformOutperformhold
Jun 28, 2024Canaccord GenuityBuyBuyhold
Jun 28, 2024NeedhamBuyBuyhold
Jun 28, 2024BarclaysEqual-WeightEqual-Weighthold
Apr 30, 2024Wells FargoEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Mar 21 Mar 22 Mar 23 Feb 24 Mar 25 Mar 26 Mar 27 Feb 28 Mar 29
Mar 21Mar 22Mar 23Feb 24Mar 25Mar 26Mar 27Feb 28Mar 29
Reported---------
Avg Forecast$-1.34$-1.82$-6.49$-1.37$-1.37$-0.85$-0.61$-0.51$0.36
High Forecast$-1.30$-1.76$-6.29$-1.29$-0.90$-0.63$-0.25$-0.49$0.37
Low Forecast$-1.41$-1.91$-6.61$-1.43$-2.39$-1.06$-1.01$-0.52$0.35
Surprise %---------

Revenue Forecast

$150M $290M $430M $570M $710M $850M Mar 21 Mar 22 Mar 23 Feb 24 Mar 25 Mar 26 Mar 27 Feb 28 Mar 29
Mar 21Mar 22Mar 23Feb 24Mar 25Mar 26Mar 27Feb 28Mar 29
Reported---$414.29M-----
Avg Forecast$167.81M$308.00M$363.54M$413.46M$464.93M$523.09M$589.45M$664.97M$790.00M
High Forecast$174.04M$319.45M$368.47M$414.28M$467.25M$532.68M$593.20M$673.99M$800.71M
Low Forecast$163.38M$299.88M$354.87M$412.68M$460.60M$503.13M$585.71M$649.11M$771.15M
Surprise %---0.20%-----

Net Income Forecast

$-500M $-390M $-280M $-170M $-60M $50M Mar 21 Mar 22 Mar 23 Feb 24 Mar 25 Mar 26 Mar 27 Feb 28 Mar 29
Mar 21Mar 22Mar 23Feb 24Mar 25Mar 26Mar 27Feb 28Mar 29
Reported---$-99.81M-----
Avg Forecast$-100.62M$-136.31M$-486.31M$-122.73M$-166.08M$-67.02M$-56.62M$-38.02M$26.97M
High Forecast$-97.17M$-131.63M$-471.22M$-92.88M$-67.69M$-47.15M$-18.57M$-36.84M$27.44M
Low Forecast$-105.49M$-142.90M$-494.88M$-152.59M$-179.08M$-79.57M$-75.73M$-38.69M$26.13M
Surprise %----18.68%-----

ACCD Forecast FAQ

Is Accolade stock a buy?

Accolade stock has a consensus rating of Hold, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Accolade is a neutral investment for most analysts.

What is Accolade's price target?

Accolade's price target, set by 16 Wall Street analysts, averages $7.03 over the next 12 months. The price target range spans from $7.03 at the low end to $7.03 at the high end, suggesting a potential 0.14% change from the previous closing price of $7.02.

How does Accolade stock forecast compare to its benchmarks?

Accolade's stock forecast shows a 0.14% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the healthcare information services stocks industry (36.10%).

What is the breakdown of analyst ratings for Accolade over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 8.33% Strong Buy, 8.33% Buy, 83.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 8.33% Strong Buy, 8.33% Buy, 83.33% Hold, 0% Sell, 0% Strong Sell.

What is Accolade’s EPS forecast?

Accolade's average annual EPS forecast for its fiscal year ending in March 2025 is $-1.37, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-0.85 in 2026, $-0.61 in 2027, $-0.51 in 2028, and $0.36 in 2029.

What is Accolade’s revenue forecast?

Accolade's average annual revenue forecast for its fiscal year ending in March 2025 is $464.93M, reflecting a 12.22% increase from the reported $414.29M in 2024. The forecast for 2026 is $523.09M, followed by $589.45M for 2027, $664.97M for 2028, and $790M for 2029.

What is Accolade’s net income forecast?

Accolade's net income forecast for the fiscal year ending in March 2025 stands at $-166M, representing an 66.40% increase from the reported $-99.805M in 2024. Projections indicate $-67.022M in 2026, $-56.615M in 2027, $-38.015M in 2028, and $26.97M in 2029.